ABT

2025Q2BMO

Abbott Laboratories primary · HEALTHCARE · MEDICAL DEVICES

Report 2025-07-17 · Fiscal end 2025-06-30 · Features as of 2025-07-16

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS1.26
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.0%
IV front—
P/C full—
P/C front—
Features as of2025-07-16

Run-up

Close—
Ret 5d-1.1%
Ret 10d-3.3%
Ret 20d-1.7%
Ret 30d-1.4%

Post-Earnings Data

Results & reaction

Print

Actual EPS
1.26—
Estimated EPS1.26
Actual revenue
11.1B
Surprise %0.0%
Beat / miss—
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction-4.8%
Implied vs actual

Implied 4.0%Actual 3.9%

Gap reaction-3.9%
Day result-8.5%
Next-day upNo
Realized / IV1.00×

Post tape

Post 5d+4.3%
Post 10d+4.7%
Post volume27.6M
Vol ×10d5.00×
Vol ×20d4.35×
Post range5.6%